San Mateo, CA, United States of America

Irene Chen

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 3.9

ph-index = 4

Forward Citations = 45(Granted Patents)


Company Filing History:


Years Active: 2017-2021

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Irene Chen: Innovator in Pharmaceutical Chemistry

Introduction

Irene Chen is a prominent inventor based in San Mateo, California. She has made significant contributions to the field of pharmaceutical chemistry, holding a total of 5 patents. Her work focuses on the development of novel crystalline forms and pharmaceutical formulations that have therapeutic applications.

Latest Patents

Irene's latest patents include innovative crystalline forms of complex compounds. One notable invention is related to crystalline forms of (2R,5S,13aR)-8-hydroxy-7,9-dioxo-N-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2′:4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide. This invention encompasses pharmaceutical formulations and their therapeutic uses. Another significant patent involves sodium (2R,5S,13aR)-7,9-dioxo-10-((2,4,6-trifluorobenzyl)carbamoyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2′:4,5]pyrazino[2,1-b][1,3]oxazepin-8-olate Form I, which is aimed at treating or preventing HIV infections.

Career Highlights

Irene Chen is currently employed at Gilead Sciences, Inc., where she continues to advance her research in pharmaceutical innovations. Her work has been instrumental in developing new treatments that address critical health issues.

Collaborations

Irene collaborates with esteemed colleagues, including Ernest A Carra and Vahid Zia, to further enhance the impact of her research and inventions.

Conclusion

Irene Chen is a trailblazer in the field of pharmaceutical chemistry, with a focus on innovative solutions for health challenges. Her contributions through patents and collaborations highlight her commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…